Stay updated on Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.

Latest updates to the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded revision v3.4.2 to the record history and removed v3.4.1. These are minor maintenance changes that do not affect study data or user-facing content.SummaryDifference0.1%

- Check20 days agoChange DetectedThe record history shows a new revision entry v3.4.1 and removal of v3.4.0, indicating a minor update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedUI text and labeling updates include the addition of a 'Show glossary' label, color-coding explanations for additions and deletions, and a new 'Revision: v3.4.0' tag, with capitalization tweaks like 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedRevision v3.3.4 was added to the study record history. Revision v3.3.3 was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check91 days agoChange DetectedThe Record History now includes an addition of Revision v3.3.2 and a deletion of Revision v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.